{"version":"1.0","provider_name":"Philadelphia Immunization Program","provider_url":"https:\/\/vaccines.phila.gov","title":"Beyfortus (nirsevimab) Now Available Through VFC - Philadelphia Immunization Program","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"tuTxu8EIvN\"><a href=\"https:\/\/vaccines.phila.gov\/index.php\/beyfortus-nirsevimab-now-available-through-vfc\/\">Beyfortus (nirsevimab) Now Available Through VFC<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/vaccines.phila.gov\/index.php\/beyfortus-nirsevimab-now-available-through-vfc\/embed\/#?secret=tuTxu8EIvN\" width=\"600\" height=\"338\" title=\"&#8220;Beyfortus (nirsevimab) Now Available Through VFC&#8221; &#8212; Philadelphia Immunization Program\" data-secret=\"tuTxu8EIvN\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/vaccines.phila.gov\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"Beyfortus (nirsevimab) Now Available Through VFC\u00a0 On July 17, 2023, FDA licensed AstraZeneca and Sanofi\u2019s Beyfortus (nirsevimab) for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD). On August 3, the ACIP voted unanimously to recommend nirsevimab for use in infants during...","thumbnail_url":"https:\/\/vaccines.phila.gov\/wp-content\/uploads\/2023\/10\/Screenshot-beyfortus-advisory.png","thumbnail_width":871,"thumbnail_height":193}